GURU.Markets stock price, segment price, and overall market index valuation
The company's share price Allarity Therapeutics
Allarity Therapeutics is an oncology company developing personalized cancer treatments. Its stock price is a bet on the success of its diagnostic platform, which tailors therapy to each patient. The stock price reflects high volatility and dependence on research results.
Share prices of companies in the market segment - Miscellaneous oncology
Allarity Therapeutics is a Danish biopharmaceutical company that uses its diagnostic platform to select personalized therapies for cancer patients. We've categorized it under "Various Oncology." The chart below shows how the market views personalized medicine approaches.
Broad Market Index - GURU.Markets
Allarity Therapeutics is a Danish oncology company that uses its platform to match patients most likely to respond to its drugs. Its approach to personalized medicine makes it part of the GURU.Markets index. The chart below compares its performance with the market.
Change in the price of a company, segment, and market as a whole per day
ALLR - Daily change in the company's share price Allarity Therapeutics
For Allarity Therapeutics, an oncology company, daily price change is a measure of extreme volatility. It reflects investor reactions to news about clinical trials and partnerships, and is an important metric for assessing risk.
Daily change in the price of a set of shares in a market segment - Miscellaneous oncology
Allarity Therapeutics, Inc. is an oncology company. This chart illustrates the extreme volatility of the biotech sector. Comparison with ALLR's performance, with its personalized medicine platform, helps to assess it as a high-risk asset.
Daily change in the price of a broad market stock, index - GURU.Markets
Allarity Therapeutics is developing personalized cancer therapy based on biomarker analysis. This innovative biotech company's shares are reacting to research data. Its story is a reflection of the medtech sector's contribution to overall volatility.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization Allarity Therapeutics
Allarity Therapeutics' year-over-year performance tells the story of its approach to personalized oncology. Its 12-month market cap depends entirely on the success of its DRP® diagnostic platform, which matches patients with its targeted therapies. Success in clinical trials will confirm the value of this approach.
Annual dynamics of market capitalization of the market segment - Miscellaneous oncology
As an early-stage biotech, Allarity is a high-risk bet on science. Its performance is completely disconnected from the sector and depends on news about its personalized medicine platform. Its stock price will reflect investors' speculative belief in the potential of its developments.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
Allarity Therapeutics, a company focused on personalized oncology, is betting on a unique technology. Its stock price is driven by the success of its diagnostic platform and regulatory approvals. Its relative performance demonstrates that for such companies, investor faith in scientific breakthroughs is more important than any macroeconomic indicators.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization Allarity Therapeutics
Allarity Therapeutics is an oncology company that uses a proprietary platform to match patients with treatments. Its monthly growth is driven by progress in its clinical programs and the validation of its diagnostic approach. Partnership news is key.
Monthly dynamics of market capitalization of the market segment - Miscellaneous oncology
This chart reflects the dynamics of the volatile biotech sector. For Allarity, with its unique diagnostic platform, it's the backdrop. Its movements illustrate its struggle for FDA approval and validation of its approach to personalized oncology.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
Allarity Therapeutics is a Danish biotech company developing personalized cancer treatments using its diagnostic platform. The overall market chart provides only background information, while Allarity's performance is driven by news of clinical trials and partnerships, which is typical for the biotech sector.
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization Allarity Therapeutics
Allarity Therapeutics, an oncology company that uses a unique platform to tailor therapy to individual patients, is extremely news-sensitive. Its weekly stock price is a strong reaction to clinical trial results confirming the effectiveness of its diagnostic approach and to partnerships with pharmaceutical companies.
Weekly dynamics of market capitalization of the market segment - Miscellaneous oncology
Allarity Therapeutics operates in the volatile biopharmaceutical sector, where investor sentiment often influences all players. M&A news or general regulatory changes can lift or derail the entire segment. The chart will reveal whether ALLR is moving with the industry or whether its unique platform is forging its own path.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
Allarity Therapeutics, as a biotech company, often ignores broader market trends. Its fate depends not on GDP or inflation, but on the results of clinical trials. The chart below clearly demonstrates how ALLR shares can live a life of their own, separate from the broader market.
Market capitalization of the company, segment and market as a whole
ALLR - Market capitalization of the company Allarity Therapeutics
Allarity Therapeutics' chart tells the story of a personalized approach to cancer treatment. The company uses its diagnostic platform to identify patients who can benefit from its drugs. Its market cap dynamics reflect how investors view this complex but potentially effective strategy.
ALLR - Share of the company's market capitalization Allarity Therapeutics within the market segment - Miscellaneous oncology
Allarity Therapeutics is an oncology company that uses its DRP platform to match patients most likely to respond to a specific drug. Its market share reflects its focus on personalized medicine. The chart shows how the market views its approach to improving treatment effectiveness.
Market capitalization of the market segment - Miscellaneous oncology
Allarity Therapeutics develops oncology drugs using a unique platform to select the patients most likely to benefit from the drug. The graph below shows the market capitalization of the oncology sector, reflecting the trend toward personalized medicine.
Market capitalization of all companies included in a broad market index - GURU.Markets
Allarity Therapeutics is an oncology company that uses its diagnostic platform to identify patients most likely to benefit from its therapy. Its market cap is driven by a bet on personalized medicine. The chart below shows the weight of this approach.
Book value capitalization of the company, segment and market as a whole
ALLR - Book value capitalization of the company Allarity Therapeutics
Allarity Therapeutics is built on a unique diagnostic platform. The company's book value reflects its DRP® technology, which helps predict a patient's response to a specific cancer drug, and the rights to several drug candidates. The chart below illustrates the financial foundation of this personalized oncology business.
ALLR - Share of the company's book capitalization Allarity Therapeutics within the market segment - Miscellaneous oncology
Allarity Therapeutics, an oncology company, is focused on R&D. Its laboratories are its main tangible asset. The S_BCap_Seg chart shows its small share of physical infrastructure, which is typical for a biotech company.
Market segment balance sheet capitalization - Miscellaneous oncology
Allarity Therapeutics is an oncology company developing personalized medicine. Its approach is based on diagnostics to tailor treatment. Its assets are patents and technologies, not factories. The chart shows how intangible its business is, focusing on R&D.
Book value of all companies included in the broad market index - GURU.Markets
Allarity Therapeutics' assets comprise a personalized oncology platform. The company's book value reflects its DRP® diagnostic technology, which helps predict a patient's response to a drug, and its rights to several drugs. This provides the foundation for implementing the "right patient, right medicine" approach.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - Allarity Therapeutics
Allarity Therapeutics develops oncology drugs using patient-specific therapy selection. The company's book value is small. Its market capitalization reflects its unique DRP diagnostic platform and the hope that this personalized approach will improve the effectiveness of cancer treatment.
Market to book capitalization ratio in a market segment - Miscellaneous oncology
Allarity Therapeutics is a personalized oncology company using its treatment selection platform. Its value lies in this diagnostic technology. The chart shows how the market values its innovative approach compared to its tangible assets.
Market to book capitalization ratio for the market as a whole
Allarity Therapeutics is a biotech company that uses its diagnostic platform to match patients with targeted cancer therapy. Its value lies in this unique approach. The chart shows how the market values this innovative model of personalized medicine, rather than simply drug development.
Debts of the company, segment and market as a whole
ALLR - Company debts Allarity Therapeutics
Allarity Therapeutics, an oncology company developing personalized medicine, uses debt to fund its clinical trials. This chart shows how it raises capital to test its drugs in conjunction with diagnostic tools that tailor therapy to individual patients.
Market segment debts - Miscellaneous oncology
Allarity Therapeutics is an oncology company developing personalized therapies. Its approach is based on using a proprietary diagnostic platform to select patients most likely to respond to treatment. This chart shows its financial position, which is dependent on clinical trial success and capital raising.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio Allarity Therapeutics
Allarity Therapeutics develops oncology drugs using personalized medicine methods. This chart shows its dependence on debt. For a biotech company advancing an innovative approach to cancer treatment, debt is a risky fuel for lengthy and expensive clinical trials.
Market segment debt to market segment book capitalization - Miscellaneous oncology
Allarity Therapeutics is an oncology company using a personalized approach to cancer treatment. This chart for the biotech sector illustrates how the industry as a whole attracts capital to fund innovative but risky research. It helps evaluate the company's financial strategy in this cutting-edge field of medicine.
Debt to book value of all companies in the market
Allarity Therapeutics develops personalized cancer treatments using its proprietary platform for tailoring therapy to individual patients. This chart, which shows the market's debt-to-book value ratio, is important for assessing the investment climate in biotech. The market's willingness to fund innovative approaches determines Allarity's ability to advance its developments.
P/E of the company, segment and market as a whole
P/E - Allarity Therapeutics
Allarity Therapeutics is developing personalized oncology treatments using its diagnostic platform to identify patients most likely to benefit from a drug. This graph reflects the future of cancer treatment. Its significance reflects investors' belief that this approach will improve the chances of success in clinical trials and benefit patients.
P/E of the market segment - Miscellaneous oncology
Allarity Therapeutics is a biotech company. This chart shows the average P/E ratio for the biotech sector. Comparing the company's P/E to this benchmark allows us to understand how highly the market values its approach to personalized oncology compared to the average prospects of other biotech companies.
P/E of the market as a whole
Allarity Therapeutics is a company specializing in personalized medicine in oncology. It uses its diagnostic platform to identify patients most likely to benefit from a specific drug. This chart shows sentiment in the biotech sector. The company's valuation depends on the success of this strategy and the validation of its diagnostic tool in clinical trials.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company Allarity Therapeutics
Allarity Therapeutics is a personalized oncology company. It uses its diagnostic platform to identify patients most likely to benefit from a specific therapy. The chart reflects future revenue expectations, which depend on the success of this approach and partnerships with pharmaceutical companies.
%20P%2FE%20Allarity%20Therapeutics&width=1500&height=450&colorIndex=35&filename=GURU_Markets_-_Chart-of-the-companys-future-projected-PE-Allarity-Therapeutics&v=1772702379139 "Chart of the company's future (projected) P/E Allarity Therapeutics")
Future (projected) P/E of the market segment - Miscellaneous oncology
Allarity Therapeutics uses a proprietary diagnostic platform to identify patients most likely to respond to specific cancer therapies. This chart shows how its future revenue expectations compare to the industry average, reflecting its unique approach to personalized oncology.
%20P%2FE%20graph%20of%20the%20market%20segment%20-%20Miscellaneous%20oncology&width=1500&height=450&colorIndex=36&filename=GURU_Markets_-_Future-projected-PE-graph-of-the-market-segment-Miscellaneous-oncology&v=1772702379148 "Future (projected) P/E graph of the market segment - Miscellaneous oncology")
Future (projected) P/E of the market as a whole
Allarity Therapeutics is a Danish biotech company that uses a unique platform to tailor oncology drugs to individual patients. Its success depends on the validation of this approach and partnerships with pharmaceutical companies. This is a story about personalized medicine, not general market trends.
%20P%2FE%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=37&filename=GURU_Markets_-_Chart-of-the-future-projected-PE-of-the-market-as-a-whole&v=1772702379149 "Chart of the future (projected) P/E of the market as a whole")
Profit of the company, segment and market as a whole
Company profit Allarity Therapeutics
Allarity Therapeutics is a biotech company using its proprietary platform to develop personalized cancer therapies. It selects patients for treatment based on biomarkers. While in the research stage, the company incurs significant R&D expenditures. This chart reflects its investment in developing a "precision medicine" approach to oncology.
Profit of companies in the market segment - Miscellaneous oncology
Allarity Therapeutics is a company using its proprietary platform to develop personalized cancer therapies. This chart shows the profitability of the oncology sector. Its approach is based on biomarker-based treatment selection. The success of this strategy could improve treatment efficacy and drive the entire field of personalized medicine.
Overall market profit
Allarity Therapeutics is a company specializing in personalized medicine in oncology. It uses its diagnostic platform to select patients most likely to benefit from a particular drug. Its success depends on the validation of this approach. This chart illustrates general market cycles, as Allarity works at the forefront of cancer treatment innovation.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company Allarity Therapeutics
Allarity Therapeutics is a company using a unique platform to deliver personalized therapy to cancer patients. This chart reflects analysts' expectations for future profits, which depend on the success of its diagnostic tests and partnerships with pharmaceutical companies. It demonstrates the market's confidence in the future of personalized medicine in oncology.
%20profit%20of%20the%20company%20Allarity%20Therapeutics&width=1500&height=450&colorIndex=41&filename=GURU_Markets_-_Graph-of-future-projected-profit-of-the-company-Allarity-Therapeutics&v=1772702379174 "Graph of future (projected) profit of the company Allarity Therapeutics")
Future (predicted) profit of companies in the market segment - Miscellaneous oncology
Allarity Therapeutics is a personalized oncology company that uses its platform to match patients with the most effective treatments. This chart shows profitability forecasts for the oncology sector. It reflects expectations for the growth of precision medicine in cancer treatment.
%20profits%20of%20companies%20in%20a%20market%20segment%20-%20Miscellaneous%20oncology&width=1500&height=450&colorIndex=42&filename=GURU_Markets_-_Graph-of-future-predicted-profits-of-companies-in-a-market-segment-Miscellaneous-oncology&v=1772702379176 "Graph of future (predicted) profits of companies in a market segment - Miscellaneous oncology")
Future (predicted) profit of the market as a whole
Allarity Therapeutics develops personalized cancer treatments. For a company in the research stage, market profit forecasts are important as an indicator of funding availability. During periods of economic optimism, investors are more willing to invest in risky biotech, which is vital for the company's continued development.
%20profits%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=43&filename=GURU_Markets_-_Chart-of-future-predicted-profits-of-the-market-as-a-whole&v=1772702379186 "Chart of future (predicted) profits of the market as a whole")
P/S of the company, segment and market as a whole
P/S - Allarity Therapeutics
Allarity Therapeutics is a personalized oncology company. It uses its diagnostic platform to identify patients who can benefit from its drugs. The P/S will reflect the success of both its drugs and its unique diagnostic technology once they are commercialized.
P/S market segment - Miscellaneous oncology
Allarity Therapeutics is a biopharmaceutical company that uses its platform to identify patients most likely to respond to specific cancer therapies. This personalized medicine approach can improve treatment effectiveness. The chart shows how the market values their diagnostic platform and pipeline of drug candidates.
P/S of the market as a whole
Allarity Therapeutics is a biotech company that uses a proprietary platform to identify patients most likely to benefit from specific cancer drugs. The company has no commercial revenue. This chart, showing its estimated real revenue, highlights Allarity's commitment to the future of personalized oncology.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company Allarity Therapeutics
Allarity Therapeutics is a precision oncology company that uses its diagnostic platform to identify patients most likely to respond to specific therapies. This chart reflects investor expectations for future revenue, which hinge on the success of its drugs combined with its unique diagnostic approach.
%20P%2FS%20Allarity%20Therapeutics&width=1500&height=450&colorIndex=47&filename=GURU_Markets_-_The-graph-of-the-companys-future-projected-PS-Allarity-Therapeutics&v=1772702379199 "The graph of the company's future (projected) P/S Allarity Therapeutics")
Future (projected) P/S of the market segment - Miscellaneous oncology
Allarity Therapeutics, Inc. is an oncology company that uses its DRP® platform to identify patients most likely to respond to specific cancer therapies. This chart shows how the market values future revenue from its approach to personalized medicine. It compares it to other oncology companies, reflecting the market's belief in its diagnostic technology.
%20P%2FS%20market%20segment%20graph%20-%20Miscellaneous%20oncology&width=1500&height=450&colorIndex=48&filename=GURU_Markets_-_Future-projected-PS-market-segment-graph-Miscellaneous-oncology&v=1772702379203 "Future (projected) P/S market segment graph - Miscellaneous oncology")
Future (projected) P/S of the market as a whole
Allarity Therapeutics is a personalized oncology company. It uses a proprietary diagnostic platform to identify patients most likely to benefit from a specific drug. This chart shows overall market revenue expectations, and ALLR illustrates how the trend toward personalized medicine is changing approaches to cancer treatment.
%20P%2FS%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=49&filename=GURU_Markets_-_Chart-of-the-future-projected-PS-of-the-market-as-a-whole&v=1772702379211 "Chart of the future (projected) P/S of the market as a whole")
Sales of the company, segment and market as a whole
Company sales Allarity Therapeutics
Allarity Therapeutics is a clinical-stage oncology company that uses its unique platform to identify patients most likely to respond to therapy. Because its drugs are in development, sales revenue is not included in this chart. Future revenue will depend on the commercialization of its approach to personalized medicine.
Sales of companies in the market segment - Miscellaneous oncology
Allarity Therapeutics is a biotech company using its diagnostic platform to develop personalized cancer therapies. Currently, its revenue, if any, may come from partnerships related to its diagnostic technology. The chart reflects these financial flows.
Overall market sales
Allarity Therapeutics is a personalized oncology company. Its approach is based on biomarker-based treatment selection. The company's success depends on the effectiveness of its diagnostic platform and partnerships with pharmaceutical companies. This timeline is not relevant to Allarity, whose business is driven by scientific and clinical factors.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company Allarity Therapeutics
Allarity Therapeutics is a precision oncology company that uses its diagnostic platform to identify patients most likely to respond to specific therapies. Its revenue forecast hinges on the success of this strategy. This chart shows analyst expectations for its personalized approach to cancer treatment.
%20sales%20of%20the%20company%20Allarity%20Therapeutics&width=1500&height=450&colorIndex=53&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-the-company-Allarity-Therapeutics&v=1772702379243 "Schedule of future (projected) sales of the company Allarity Therapeutics")
Future (projected) sales of companies in the market segment - Miscellaneous oncology
Allarity Therapeutics is a precision oncology biotech company. It uses a proprietary diagnostic platform to match patients most likely to benefit from their therapy. This chart shows projected revenue for the entire oncology sector, highlighting the growing demand for personalized treatments.
%20sales%20of%20companies%20in%20the%20market%20segment%20-%20Miscellaneous%20oncology&width=1500&height=450&colorIndex=54&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-companies-in-the-market-segment-Miscellaneous-oncology&v=1772702379245 "Schedule of future (projected) sales of companies in the market segment - Miscellaneous oncology")
Future (projected) sales of the market as a whole
Allarity Therapeutics is a biotech company specializing in personalized oncology. It uses its platform to identify patients most likely to benefit from specific drugs. This graph of overall market expectations reflects the investment climate, which is important for funding innovative approaches to cancer treatment.
%20sales%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=55&filename=GURU_Markets_-_Schedule-of-future-predicted-sales-of-the-market-as-a-whole&v=1772702379249 "Schedule of future (predicted) sales of the market as a whole")
Marginality of the company, segment and market as a whole
Company marginality Allarity Therapeutics
Allarity Therapeutics is a personalized oncology company. It uses its diagnostic platform to identify patients most likely to benefit from a particular therapy. This graph shows the path to monetization for this approach, which depends on the success of clinical trials.
Market segment marginality - Miscellaneous oncology
Allarity Therapeutics is a precision oncology company that uses its unique platform to match patients with the most effective cancer treatments. This chart reflects the average profitability of the biotech sector, allowing you to assess how Allarity's innovative approach can improve the success of its therapies and provide a commercial advantage.
Market marginality as a whole
Allarity Therapeutics develops personalized cancer treatments using its diagnostic platform to tailor therapy to individual patients. This overall profitability chart doesn't reflect the company's business, which operates at the intersection of pharmaceuticals and diagnostics and aims to make cancer treatment more precise and effective.
Employees in the company, segment and market as a whole
Number of employees in the company Allarity Therapeutics
Allarity Therapeutics is a precision oncology company. It uses its diagnostic platform to identify patients who might benefit from its drugs. Its small team consists of scientists and clinicians. This graph shows the size of its focused group working at the intersection of cancer diagnostics and therapy.
Share of the company's employees Allarity Therapeutics within the market segment - Miscellaneous oncology
Allarity Therapeutics is a biopharmaceutical company using a unique platform to develop personalized cancer therapies. This chart illustrates its innovative approach to cancer treatment. It reflects the proportion of bioinformaticians and oncologists working at Allarity to find the right drug for the right patient.
Number of employees in the market segment - Miscellaneous oncology
Allarity Therapeutics develops personalized cancer treatments using its drug selection platform. This chart shows employment in the oncology sector. The growth in the number of specialists in this field reflects the shift toward precision medicine, where treatment is tailored based on individual tumor genetic characteristics.
Number of employees in the market as a whole
Allarity Therapeutics A/S is a Danish biotech company specializing in personalized medicine in oncology. The development of targeted therapies is the future of cancer treatment. This graph shows overall employment, and while these companies are small, they are at the forefront of science and create jobs for exceptional specialists.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company Allarity Therapeutics (ALLR)
Allarity Therapeutics is an oncology company that uses a personalized approach. Its value lies in its unique diagnostic platform. This chart shows how the market values this intellectual capital. The high cost per employee is a premium for the technology that promises to make cancer treatment more effective.
%20of%20the%20company%20Allarity%20Therapeutics%20(ALLR)&width=1500&height=450&colorIndex=63&filename=GURU_Markets_-_Chart-of-market-capitalization-per-employee-in-thousands-of-dollars-of-the-company-Allarity-Therapeutics-ALLR&v=1772702379279 "Chart of market capitalization per employee (in thousands of dollars) of the company Allarity Therapeutics (ALLR)")
Market capitalization per employee (in thousands of dollars) in the market segment - Miscellaneous oncology
Allarity Therapeutics develops oncology drugs using its proprietary platform for tailoring therapy to individual patients. Its market value per employee reflects the value of this unique personalized medicine technology. Its high value reflects investors' confidence in its potential to improve the effectiveness of cancer treatment.
%20by%20market%20segment%20-%20Miscellaneous%20oncology&width=1500&height=450&colorIndex=64&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-by-market-segment-Miscellaneous-oncology&v=1772702379294 "Market capitalization per employee (in thousands of dollars) by market segment - Miscellaneous oncology")
Market capitalization per employee (in thousands of dollars) for the overall market
Allarity Therapeutics is a personalized oncology company that uses its diagnostic platform to match patients most likely to respond to specific therapies. This chart reflects how the market appreciates this innovative approach, where the team's intellect is driving improved cancer treatment outcomes.
%20for%20the%20overall%20market&width=1500&height=450&colorIndex=65&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-for-the-overall-market&v=1772702379297 "Market capitalization per employee (in thousands of dollars) for the overall market")
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company Allarity Therapeutics (ALLR)
Allarity Therapeutics is an oncology company that uses its AI platform (DRP) to match patients with its drugs. It's an R&D business. This chart, in negative territory, shows how much capital is being burned per scientist and data scientist trying to prove the effectiveness of this personalized approach.
%20Chart%20Allarity%20Therapeutics%20(ALLR)&width=1500&height=450&colorIndex=66&filename=GURU_Markets_-_Company-Profit-Per-Employee-in-thousands-of-dollars-Chart-Allarity-Therapeutics-ALLR&v=1772702379298 "Company Profit Per Employee (in thousands of dollars) Chart Allarity Therapeutics (ALLR)")
Profit per employee (in thousands of dollars) in the market segment - Miscellaneous oncology
Allarity Therapeutics is a biotech company using its platform to develop personalized cancer treatments. This chart highlights the value of their diagnostic approach. It illustrates how technology that enables patient selection for therapy can improve treatment effectiveness and, consequently, create a product with high potential for profit.
%20in%20the%20market%20segment%20-%20Miscellaneous%20oncology&width=1500&height=450&colorIndex=67&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-in-the-market-segment-Miscellaneous-oncology&v=1772702379299 "Chart of profit per employee (in thousands of dollars) in the market segment - Miscellaneous oncology")
Profit per employee (in thousands of dollars) for the market as a whole
Allarity Therapeutics is a biotech company developing personalized cancer treatments using its DRP diagnostic platform. This chart reflects R&D expenditures per employee. The company is investing in its unique diagnostic platform to improve treatment effectiveness and achieve a high return on investment in the future.
%20for%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=68&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-for-the-market-as-a-whole&v=1772702379300 "Chart of profit per employee (in thousands of dollars) for the market as a whole")
Sales to employees of the company, segment and market as a whole
Sales per company employee Allarity Therapeutics (ALLR)
Allarity Therapeutics is an oncology company developing personalized treatments. This graph doesn't reflect commercial activity during the clinical trials stage. It represents scientific potential. Successful commercialization of its diagnostic platform and drugs will lead to a sharp increase in this metric.
&width=1500&height=450&colorIndex=69&filename=GURU_Markets_-_Sales-chart-per-company-employee-Allarity-Therapeutics-ALLR&v=1772702379301 "Sales chart per company employee Allarity Therapeutics (ALLR)")
Sales per employee in the market segment - Miscellaneous oncology
Allarity Therapeutics (ALLR) is a Danish oncology company that uses its platform (DRP®) to predict patient response to specific cancer drugs. This chart shows the average revenue per employee in the pharmaceutical segment. For Allarity, which focuses on R&D and diagnostics, comparison to this benchmark (zero) underscores their focus on personalized medicine.
Sales per employee for the market as a whole
Allarity Therapeutics (ALLR) is a biotech company using AI to select oncology drugs. It's an R&D company trying to commercialize its diagnostic platform. Its revenue is currently close to zero. An increase would indicate that their platform is truly helping them find patients and generate revenue.
Short shares by company, segment and market as a whole
Shares shorted by company Allarity Therapeutics (ALLR)
Allarity Therapeutics is a biotech company trying to use AI to match patients with specific oncology drugs. This chart shows the lack of confidence in their platform. The bears are betting that their diagnostic approach doesn't work or that the drugs they're promoting are ineffective, and the company will burn through all its money.
&width=1500&height=450&colorIndex=72&filename=GURU_Markets_-_Short-Shares-Chart-for-the-Company-Allarity-Therapeutics-ALLR&v=1772702379310 "Short Shares Chart for the Company Allarity Therapeutics (ALLR)")
Shares shorted by market segment - Miscellaneous oncology
Allarity Therapeutics (ALLR) is a biotech company attempting to revive failed oncology drugs by using its diagnostic platform (DRP) to find patients who can benefit from them. This chart highlights the pessimism in the sector. The growing short position across the industry is a bet that this model won't work. Investors don't believe ALLR can prove to the FDA that a "failed" drug has suddenly become effective.
Shares shorted by the overall market
Allarity (ALLR) is a clinical-stage biotech company. Its survival depends entirely on access to capital markets. When this market pessimism indicator rises, it signals a "venture winter." Investors panic and flee unprofitable biotechs, fearing ALLR won't be able to raise capital.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator Allarity Therapeutics (ALLR)
Allarity Therapeutics uses AI to develop personalized cancer treatments. It's a combination of two of the hottest sectors—biotech and AI. This chart shows the feverish anticipation. It could instantly overheat on any news about partnerships or successes of their AI platform, reflecting the high speculative interest.
&width=1500&height=450&colorIndex=75&filename=GURU_Markets_-_RSI-14-indicator-chart-for-the-companys-stock-Allarity-Therapeutics-ALLR&v=1772702379317 "RSI 14 indicator chart for the company's stock Allarity Therapeutics (ALLR)")
RSI 14 Market Segment - Miscellaneous oncology
Allarity Therapeutics is a biopharmaceutical company specializing in personalized oncology. Their DRP platform is a diagnostic tool for predicting patient response to therapy. This chart reflects the overall sentiment in the oncology sector and helps assess how overheated this speculative biotech segment is.
RSI 14 for the overall market
Allarity (ALLR) is a biotech R&D company. Like everything in its sector, it's critically dependent on this schedule. Market euphoria is an easy way to raise hundreds of millions of dollars for research. Market panic is the risk of running out of money before its breakthrough technologies reach patients.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast ALLR (Allarity Therapeutics)
Allarity Therapeutics is a Danish biotech company that uses its Drug Response Predictor (DRP) platform to select targeted therapies for cancer patients. This chart shows the speculative average 12-month price target from analysts based on their belief in this diagnostic R&D platform.
&width=1500&height=450&colorIndex=78&filename=GURU_Markets_-_A-chart-showing-analyst-consensus-forecasts-for-the-expected-stock-price.-ALLR-Allarity-Therapeutics&v=1772702379346 "A chart showing analyst consensus forecasts for the expected stock price. ALLR (Allarity Therapeutics)")
The difference between the consensus estimate and the actual stock price ALLR (Allarity Therapeutics)
Allarity is a precision oncology company. It uses its diagnostic platform (DRP) to select patients who are *certainly* likely to benefit from its drug. This chart shows the difference between the market valuation and the consensus estimate. It reveals whether experts believe in this "diagnostics plus therapy" R&D strategy.
&width=1500&height=450&colorIndex=79&filename=GURU_Markets_-_A-chart-showing-the-difference-between-the-consensus-forecast-and-the-actual-stock-price.-ALLR-Allarity-Therapeutics&v=1772702379353 "A chart showing the difference between the consensus forecast and the actual stock price. ALLR (Allarity Therapeutics)")
Analyst consensus forecast for stock prices by market segment - Miscellaneous oncology
Allarity Therapeutics is a Danish biotech company focused on "personalized" oncology. It's developing a test that selects the right patients for its drug. This chart shows general expectations for the oncology sector, reflecting whether experts believe in this "test + drug" R&D strategy.
Analysts' consensus forecast for the overall market share price
Allarity Therapeutics is a Danish biotech company that uses AI (the DRP platform) to identify patients most likely to benefit from its cancer therapy. This is "personalized" oncology. This chart shows the overall "risk appetite" in the market. For Allarity, a high-risk company, overall market optimism is critical to attracting research capital.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index Allarity Therapeutics
Allarity is a biotech diagnostics company. Their signature feature is the DRP® platform, which predicts which patients will benefit from which drug before treatment. They use this to rescue failed R&D drugs. This chart is a summary indicator of their R&D model. It reflects their (very slow) path to approval and their belief that diagnostics come first.
AKIMA Market Segment Index - Miscellaneous oncology
Allarity Therapeutics (ALLR) is an oncology company with a unique approach. They use their DRP (Drug Response Predictor) platform to predict which patients will respond to their targeted therapies. The chart shows the average index for the segment, helping investors assess how this drug-plus-diagnostics strategy compares to the average.
The AKIM Index for the overall market
Allarity Therapeutics is a precision medicine company that uses diagnostic testing (DRP) to select patients who will benefit from existing cancer drugs. This chart, which reflects the market average, provides a macro backdrop. It helps assess how this drug "rescue" story compares to overall economic trends.
